Literature DB >> 16055583

Chlamydia screening in a Health Plan before and after a national performance measure introduction.

Gale R Burstein1, Mark H Snyder, Deborah Conley, Daniel R Newman, Cathleen M Walsh, Guoyu Tao, Kathleen L Irwin.   

Abstract

OBJECTIVE: To evaluate chlamydia-screening policies, testing practices, and the proportion testing positive in response to the new Health Plan Employer Data and Information Set (HEDIS) chlamydia-screening performance measure in a large commercial health plan.
METHODS: We interviewed health plan specialty departmental chiefs to describe interventions used to increase chlamydia screening and examined electronic medical records of 15- to 26-year-old female patients--37,438 from 1998 to 1999 and 37,237 from 2000 to 2001--who were classified as sexually active by HEDIS specifications to estimate chlamydia testing and positive tests 2 years before and after the HEDIS measure introduction.
RESULTS: In January 2000, the obstetrics and gynecology department instituted a policy to collect chlamydia tests at the time of routine Pap tests on all females 26 years old or younger by placing chlamydia swabs next to Pap test collection materials. Other primary care departments provided screening recommendations and provider training. During 1998-1999, 57% of eligible female patients seen by obstetrics and gynecology exclusively and 63% who were also seen by primary care were tested for chlamydia; in 2000-2001 the proportions tested increased to 81% (P < .001) and 84% (P < .001). Proportions tested by other primary care specialists did not increase substantially: 30% in 1998-1999 to 32% in 2000-2001. The proportion of females testing positive remained high after testing rates increased: 8% during 1998-1999 and 7% during 2000-2001, and the number of newly diagnosed females increased 10%.
CONCLUSION: After the obstetrics and gynecology department introduced a simple systems-level change in response to the HEDIS measure, the proportion of females chlamydia-tested and number of newly diagnosed females increased.

Entities:  

Mesh:

Year:  2005        PMID: 16055583     DOI: 10.1097/01.AOG.0000171119.81704.51

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  Chlamydia screening of adolescent females: a survey of providers in Hawaii.

Authors:  Chika Muto McGrath; Alan R Katz; Maria Veneranda C Lee; Roger W Rochat
Journal:  J Community Health       Date:  2011-04

2.  Testing adolescents for sexually transmitted infections in urban primary care practices: results from a baseline study.

Authors:  Susan E Rubin; Elizabeth M Alderman; Jason Fletcher; Giselle Campos; Lucia F O'Sullivan; M Diane McKee
Journal:  J Prim Care Community Health       Date:  2011-04-14

3.  Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics.

Authors:  Sarah Goldenkranz Salomon; Elizabeth Torrone; Wendy Nakatsukasa-Ono; David N Fine
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

4.  Screening for nonviral sexually transmitted infections in adolescents and young adults.

Authors: 
Journal:  Pediatrics       Date:  2014-07       Impact factor: 7.124

5.  The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans.

Authors:  Chirag G Patel; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

6.  Confusion regarding cervical cancer screening and chlamydia screening among sexually active young women.

Authors:  Oluwatobi Awele Ogbechie; Michele R Hacker; Laura E Dodge; Mitalee Milan Patil; Hope A Ricciotti
Journal:  Sex Transm Infect       Date:  2011-11-28       Impact factor: 3.519

Review 7.  Chlamydia trachomatis Infection in minority adolescent women: a public health challenge.

Authors:  Christie M J L Cooksey; Erica K Berggren; Jennifer Lee
Journal:  Obstet Gynecol Surv       Date:  2010-11       Impact factor: 2.347

8.  Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.

Authors:  Kwame Owusu-Edusei; Karen W Hoover; Thomas L Gift
Journal:  Am J Prev Med       Date:  2016-03-04       Impact factor: 5.043

Review 9.  Sexually Transmitted Disease Prevention Policies in the United States: Evidence and Opportunities.

Authors:  Jami S Leichliter; Naomi Seiler; Dan Wohlfeiler
Journal:  Sex Transm Dis       Date:  2016-02       Impact factor: 2.830

10.  Systems Approaches to Improving Rates of Extragenital Chlamydia and Gonorrhea Screening Among Men Who Have Sex With Men Engaged in Human Immunodeficiency Virus Care.

Authors:  Kyle T Bernstein
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.